- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05883397
Enhanced Hippocampal Neuroplasticity for Surfacing of Inaccessible Traumatic Memories in Veterans With PTSD
Hyperbaric oxygen therapy (HBOT) includes the inhalation of 100% oxygen at pressures exceeding one atmosphere absolute. HBOT has been applied worldwide, mostly for chronic non-healing wounds. Our team demonstrated that HBOT induced hippocampal neuroplasticity in veterans with long-standing treatment-resistant PTSD; this led to enhanced memory recovery and significant improvement in PTSD symptoms.
Both physical activity, such as aerobic exercise, and cognitive training were shown to support neurogenesis in the hippocampus. Therefore, the current study aims to evaluate whether hippocampal training, induced by physical and cognitive training, will augment the hippocampal neuroplasticity effect of HBOT and further enhance recovery of inaccessible memories in veterans with PTSD.
The protocol will include forty male veterans aged 25 to 60 years, with combat-associated PTSD and peritraumatic amnesia, who will receive either HBOT alone or HBOT and hippocampal training. The HBOT protocol will consist of 60 daily sessions, 90-minutes each, five days a week. Hippocampal training will combine physical and cognitive training 3 times per week, prior to HBOT sessions. Detailed psychological evaluation, anatomic and functional MRI, electroencephalogram and autonomic nervous system data will be obtained at baseline, and during and after treatment.
The proposed study offers a new approach of biological treatment for memory manipulations. The findings will help elucidate the mechanism of PTSD-related memory impairment and is expected to contribute to the development of biological memory manipulations for treating PTSD and other memory-related conditions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Our memory constructs a sense of coherence and defines the way we perceive the world. Effective encoding of memories in an adequate context, and their deliberate retrieval at a later time, are crucial for maintaining biographic continuity, and are both heavily dependent on hippocampal function.
Post-traumatic stress disorder (PTSD) can be considered a prototype disorder in which a stressogenic event leads to hippocampal malfunction and mal-encoding of a traumatic memory. Persistent hippocampal dysfunction contributes to the unremitting nature of PTSD years after the acute event. The upshot is not only amnesia, but also difficulty in memory integration in the context of time and location, and the feeling that the traumatic event is present all the time and everywhere. Improved hippocampal function may contribute to better access to memories of a traumatic event and to memory contextualization and neutralization. Memory processing is essential for PTSD recovery.
Hyperbaric oxygen therapy (HBOT) includes the inhalation of 100% oxygen at pressures exceeding one atmosphere absolute. HBOT has been applied worldwide, mostly for chronic non-healing wounds. Our team demonstrated that HBOT induced hippocampal neuroplasticity in veterans with long-standing treatment-resistant PTSD; this led to enhanced memory recovery and significant improvement in PTSD symptoms. The investigators also demonstrated effects of HBOT on memory recovery among women with fibromyalgia due to childhood sexual abuse.
Both physical activity, such as aerobic exercise, and cognitive training were shown to support neurogenesis in the hippocampus. Therefore, the current study aims to evaluate whether hippocampal training, induced by physical and cognitive training, will augment the hippocampal neuroplasticity effect of HBOT and further enhance recovery of inaccessible memories in veterans with PTSD.
The protocol will include forty male veterans aged 25 to 60 years, with combat-associated PTSD and peritraumatic amnesia, who will receive either HBOT alone or HBOT and hippocampal training. The HBOT protocol will consist of 60 daily sessions, 90-minutes each, five days a week. Hippocampal training will combine physical and cognitive training 3 times per week, prior to HBOT sessions. Detailed psychological evaluation, anatomic and functional MRI, electroencephalogram and autonomic nervous system data will be obtained at baseline, and during and after treatment.
The proposed study offers a new approach of biological treatment for memory manipulations. The findings will help elucidate the mechanism of PTSD-related memory impairment, and is expected to contribute to the development of biological memory manipulations for treating PTSD and other memory-related conditions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: keren Doenyas-Barak, MD
- Phone Number: 0544215487
- Email: kerendoenyas@gmail.com
Study Locations
-
-
-
Ramla, Israel, 70300
- Recruiting
- Assaf-Harofeh Medical Center
-
Contact:
- Shai Efrati, MD
- Phone Number: 97289779395
- Email: hbo@asaf.health.gov.il
-
Contact:
- keren doenyas-barak, MD
- Phone Number: 97289779395
- Email: PTSD-hbo@shamir.gov.il
-
Principal Investigator:
- keren doenyas, MD
-
Principal Investigator:
- Shai Efrati, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of PTSD
- A history of trauma of at least one course of trauma-focused psychotherapy
- The presence of peri-traumatic amnesia
Exclusion Criteria:
- A history of traumatic brain injury or any other known brain pathology except PTSD
- Active smoking
- Drugs or alcohol abuse other than prescribed cannabis
- Active asthma, lung pathology, epilepsy or otolaryngological disease incompatible with HBOT
- The presence of shards or another contraindication for MRI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: HBOT
Participants will be treated in a multiplace chamber (HAUX-Life-Support GmbH) for a total of 60 daily sessions, five days a week.
Each session will consist of 90 minutes exposure to 100% oxygen at 2 ATA (atmospheres), with five-minute air brakes every 20 minutes.
|
Participants will be treated in a multiplace chamber (HAUX-Life-Support GmbH) for a total of 60 daily sessions, five days a week.
Each session will consist of 90 minutes exposure to 100% oxygen at 2 ATA, with five-minute air breaks every 20 minutes.
|
Active Comparator: HBOT + hippocampal training
Participants will be treated in a multiplace chamber (HAUX-Life-Support GmbH) for a total of 60 daily sessions, five days a week. Each session will consist of 90 minutes exposure to 100% oxygen at 2 ATA, with five-minute air breaks every 20 minutes. Hippocampal training: This will combine physical and cognitive training. Training will be given 3 times per week, prior to the next HBOT, and more than 20 hours after the last HBOT session. |
Participants will be treated in a multiplace chamber (HAUX-Life-Support GmbH) for a total of 60 daily sessions, five days a week.
Each session will consist of 90 minutes exposure to 100% oxygen at 2 ATA, with five-minute air breaks every 20 minutes.
Hippocampal training: This will combine physical and cognitive training.
Training will be given 3 times per week, prior to the next HBOT, and more than 20 hours after the last HBOT session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in memory gaps (as assessed by the traumatic scene form)
Time Frame: through study completion, an average of 4 months
|
traumatic scene form will be used to assess memory gaps.
The intensity of each part sensation will be scored between 0 and 10 (higher score reflects stronger memory).
A time line of the event will be drown, and amnestic parts of the memory will be marked (the presumed amnestic time will be evaluated in minutes)
|
through study completion, an average of 4 months
|
Time to inaccessible memory surfacing
Time Frame: through study completion, an average of 4 months
|
Daily questionnaire will be used to assess surfacing of new memories.
The time of memory surfacing will be defined (session number)
|
through study completion, an average of 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in brain activity as assessed by fMRI (functional magnetic resonance imaging)
Time Frame: through study completion, an average of 4 months
|
Three different fMRI paradigms will be used to assess hippocampal function, prefrontal cortex activity and the response to the traumatic memory
|
through study completion, an average of 4 months
|
cognitive performance as assessed using "Neurotrax"
Time Frame: through study completion, an average of 4 months
|
Global Score is calculated based on the scores given for Memory performance, Attention, Information Processing speed, Executive Function and Motor skills. The score ranges between 0 and 100, and higher score reflects better performance. |
through study completion, an average of 4 months
|
RAVLT memory test
Time Frame: through study completion, an average of 4 months
|
The test is designed as a list-learning paradigm in which the patient hears a list of 15 nouns and is asked to recall as many words from the list as possible.
After five repetitions of free-recall, a second "interference" list (List B) is presented in the same manner, and the participant is asked to recall as many words from List B as possible.
After the interference trial, the participant is immediately asked to recall the words from List A, which she or he heard five times previously.
After a 20 min delay, the participant is asked to again recall the words from List A. After this "delayed recall" task, a list of 50 words is presented containing all of the words from Lists A and B, in addition to 20 phonemically and/or semantically similar words.
The multiple memory processes assessed as a global score, called "Total Learning" The score ranges between 0 and 100, and higher score reflects better performance.
|
through study completion, an average of 4 months
|
ROCFT memory test
Time Frame: through study completion, an average of 4 months
|
Copy Z Immediate recall Raw Delayed recall Z will be used to evaluate memory performance, higher scores reflects better performance.
|
through study completion, an average of 4 months
|
Verbal Pairs memory test
Time Frame: through study completion, an average of 4 months
|
Recall Total Score First Recall Total Score Learning Slope Delayed List Recall Score Percent retention Recognition Score will be used to evaluate memory performance, higher scores reflects better performance.
|
through study completion, an average of 4 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 90-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on HBOT
-
Assaf Harofeh MCUnknown
-
Assaf-Harofeh Medical CenterUnknownIntracranial Meningioma | Neurologic DeficitsIsrael
-
RWTH Aachen UniversityCompletedWound Healing | MicrocirculationGermany
-
Assaf-Harofeh Medical CenterCompletedFibromyalgia | Chronic Pain SyndromeIsrael
-
Abington Memorial HospitalPhiladelphia College of Osteopathic MedicineCompletedStroke | Ischemic Stroke | Chronic Stroke | Motor DysfunctionUnited States
-
Mrs. Thelma Zoegas FoundationLund University; Region Skåne Sweden; Gorthons Foundation Helsingborg SwedenCompletedDiabetes | Foot Ulcer | HealingSweden
-
Kenneth Peters, MDWilliam Beaumont HospitalsCompletedInterstitial CystitisUnited States
-
Assaf-Harofeh Medical CenterCompletedErectile Dysfunction | Hyperbaric Oxygen TherapyIsrael